Zosano Pharma Corporation

OTCPK:ZSAN.Q 주식 보고서

시가총액: US$3.4k

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Zosano Pharma 과거 수익 실적

과거 기준 확인 0/6

주요 정보

-5.0%

수익 성장률

75.3%

EPS 성장률

Medical Equipment 산업 성장8.9%
매출 성장률86.7%
자기자본 수익률-392.7%
순이익-8,375.1%
최근 수익 업데이트31 Mar 2022

최근 과거 실적 업데이트

Recent updates

Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?

Nov 02
Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?

Is Zosano Pharma (NASDAQ:ZSAN) Weighed On By Its Debt Load?

Jun 29
Is Zosano Pharma (NASDAQ:ZSAN) Weighed On By Its Debt Load?

Data supports long-term benefit of Zosano's migraine candidate; shares surge 23%

May 26

Zosano Pharma: Early PK+Safety Study In Q3 2021 May Breathe New Life Into This Biotech

Apr 30

Zosano shares rise on migraine treatment NDA resubmission update

Apr 26

Auditors Have Doubts About Zosano Pharma (NASDAQ:ZSAN)

Mar 15
Auditors Have Doubts About Zosano Pharma (NASDAQ:ZSAN)

Zosano Pharma up 21% following FDA feedback on Qtrypta application; presents Qtrypta data in migraine

Feb 01

Zosano Pharma requests FDA meeting for its Qtrypta application

Jan 04

Zosano Pharma EPS misses by $0.01

Nov 13

수익 및 비용 분석

Zosano Pharma 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

OTCPK:ZSAN.Q 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
31 Mar 221-55110
31 Dec 211-30110
30 Sep 211-31110
30 Jun 211-31110
31 Mar 210-33110
31 Dec 200-33110
30 Sep 200-34120
30 Jun 200-35120
31 Mar 200-37120
31 Dec 190-38120
30 Sep 190-39110
30 Jun 190-37100
31 Mar 190-37100
31 Dec 180-3590
30 Sep 180-3390
30 Jun 180-3280
31 Mar 180-3080
31 Dec 170-2980
30 Sep 170-2980
30 Jun 170-2980
31 Mar 170-2980
31 Dec 160-3080
30 Sep 160-3080
30 Jun 160-3170
31 Mar 160-3270
31 Dec 150-2860

양질의 수익: ZSAN.Q is currently unprofitable.

이익 마진 증가: ZSAN.Q is currently unprofitable.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: ZSAN.Q is unprofitable, and losses have increased over the past 5 years at a rate of 5% per year.

성장 가속화: Unable to compare ZSAN.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable

수익 대 산업: ZSAN.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-10%).


자기자본 수익률

높은 ROE: ZSAN.Q has a negative Return on Equity (-392.74%), as it is currently unprofitable.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기